Introducing ATS NOW, tailored education--anytime, anywhere. Watch top video sessions from our International Conference, webinars and podcasts. Discover new insights. Personalized learning — anytime, anywhere. Complimentary access is available for #ATS2026 attendees through year-end. Non-attendees may purchase a subscription at atsnow.thoracic.org/
🫁The conversations from ATS 2026 continue to shape respiratory medicine.
Whether you missed the meeting or are revisiting the data, our expert interview series highlights some of the most impactful presentations and emerging themes: from idiopathic pulmonary fibrosis and pulmonary hypertension to COPD, alpha-1 antitrypsin deficiency and global oxygen access.
Explore the key insights and hear what the experts had to say:
touchrespiratory.com/insight…@atscommunity#ATS2026#RespiratoryMedicine#Pulmonology#ClinicalResearch
Want to take your career to the next level? Apply to join the 2027 class of ATS Fellows! 📝
The ATS Fellow designation recognizes members who have made significant contributions to the fields of pulmonary, critical care, and sleep medicine through sustained service, scholarship, and leadership within the ATS.
Now is the time to take this important step in your professional journey; apply by Sept. 15: site.thoracic.org/membership…
As researchers continue to better understand idiopathic pulmonary fibrosis (IPF), the key to improved patient outcomes is clear: early diagnosis. On the ATS Breathe Easy podcast, Steven Nathan, MD, @InovaHealth, explains the current research being done on IPF and why detecting the disease is crucial.
This episode was sponsored by United Therapeutics.
Watch the full episode now or tune in wherever you listen to podcasts: piped.video/ic5O4FUk0zM
From our fellowship director: you may have faculty or trainees with ties to Venezuela, here’s an opportunity to show solidarity: Donate to
the Venezuelan American Medical Association (VAMA) earthquake relief fund
#HelpVAMAgofundme.com/f/help-vama?att…
The ATS is searching for the next Editor-in-Chief of @ATSBlueEditor. This prestigious journal publishes high-quality original research papers, reviews, and clinical trials in respiratory, critical care, and sleep medicine. Apply by Sept. 1, 2026!
Apply today: academic.oup.com/ajrccm/page…
The future of pulmonary fibrosis could be down to biomarker research. Resat Cinar, PhD, MBA, National Institute on Alcohol Abuse and Alcoholism, explains how understanding pulmonary fibrosis biomarkers can help track the disease's progression in patients.
Tune in wherever you listen to podcasts or watch the full episode on ATS NOW: atsnow.thoracic.org/media/26…
As temperatures continue to rise, those with lung disease need to take extra precautions. Check out our Patient Information Series for important information and tips for staying safe in the summer heat.
At the ATS Public Advisory Roundtable Patients and Experts Forum, speakers highlighted the important role of patient advocacy in shaping lung health research and policy. The sessions explored drug repurposing, complementary therapies, and collaborative approaches to improving care at #ATS2026. Learn more in ATS Conference News: atsconferencenews.org/par-fo…
DC Fireworks on Mall likely to cause hazardous air pollution, documents show National Park Service modeling predicts dangerous pollution around the Mall and “very unhealthy” conditions across central D.C.
washingtonpost.com/climate-e…